ask="6.29"
ask_size="100"
average_daily_volume="504202"
bid="3.55"
bid_size="5000"
book_value="3.74"
change="+0.07"
change_from_200_day_moving_average="1.56"
change_from_50_day_moving_average="-1.05"
change_from_52_week_high="-7.19"
change_From_52_week_low="0.17"
change_in_percent="+1.88%"
close="3.79"
dividend_pay_date="N/A"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-3.37"
ebitda="-41.42M"
eps_estimate_current_year="5.02"
eps_estimate_next_quarter="-0.50"
eps_estimate_next_year="-2.03"
ex_dividend_date="N/A"
float_shares="13385000"
high="3.85"
high_52_weeks="10.98"
last_trade_date="1/25/2017"
last_trade_price="3.79"
last_trade_size="356"
last_trade_time="4:00pm"
low="3.65"
low_52_weeks="3.62"
market_capitalization="85.47M"
moving_average_200_day="2.23"
moving_average_50_day="4.84"
name="Cascadian Therapeutics
Inc."
notes="N/A"
one_year_target_price="390.00"
open="3.73"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+69.92%"
percent_change_from_50_day_moving_average="-21.65%"
percent_change_from_52_week_high="-65.48%"
percent_change_from_52_week_low="+4.70%"
previous_close="3.72"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.00"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="22551000"
short_ratio="4.04"
stock_exchange="NMS"
symbol="CASC"
volume="521405"
weeks_range_52="3.62 - 10.98"
